Plasma protein targets with significant associations with altered disease risk included PCSK9, ANGPTL4, and APOB (Figure 2D), all three of which play well-characterized roles in CAD risk by regulating lipid and triglyceride metabolism. This evidence concerns the gene ANGPTL4 and coronary artery disorder.